Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

We are doing this study to test a behavioral weight loss program designed specifically for adolescent and young adult cancer survivors. Study participants will use new technology, including a digital smart scale, Fitbit activity tracker, and study iPhone app to help them lose weight.

Have you had an ACL reconstruction? UNC Orthopaedics is looking for people between 13-25 years old to participate in a one-session research study to measure muscle strength and physical performance using state-of-the-art wearable sensors. Compensation up to $320.

Is your child between the ages of 8-21, newly diagnosed with Leukemia or Lymphoma, and plans to receive chemotherapy treatment? If so, you may be able to participate in a research study investigating the feasiblity of a dietary intervention during treatment.

Interview rural parents of diverse racial and ethnic backgrounds to explore and understand parents' preferences on how their primary care providers discuss HPV vaccination with them, with the goal of increasing vaccination rates in rural NC and among underrepresented minority populations (Hablamos español). / Entrevistar a padres y madres de diferentes grupos étnicos y raciales para comprender como prefieren hablar sobre la vacuna del VPH con sus médicos de atención primaria. El objetivo es mejorar las tasas de vacunación en las zonas rurales de Carolina del Norte y entre las minorías.

In this study, we want to find out if a combination of 3 different study drugs (Cabozantinib, Ipilimumab, and Nivolumab) will affect the progression of Soft Tissue Sarcoma.

In a descriptive study, we intend to explore the comparative efficacy of culturally tailored CPR training, with five components: language variations, cultural adaptations, sex/age-specific instruction, socioeconomic adaptations, and consideration of cultural learning styles. By examining these components, we seek to identify the most effective and culturally sensitive approaches to CPR education. The primary goal is to develop a culturally tailored CPR training curriculum that raises confidence levels of individuals in performing bystander CPR, thus increasing bystander CPR rates and the likelihood of positive cardiac arrest outcomes.

The purpose of this study is to investigate North Carolinian archival repositories' disaster preparedness for climate change induced flood risks.

We are trying to understand the perceptions, attitudes, and stigmas around menstrual access and decision making for South Asians in the United States.